Candriam S.C.A. Has $2.82 Million Holdings in Cardinal Health, Inc. (NYSE:CAH)

Candriam S.C.A. lifted its holdings in Cardinal Health, Inc. (NYSE:CAH) by 13.2% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 23,827 shares of the company’s stock after acquiring an additional 2,782 shares during the period. Candriam S.C.A.’s holdings in Cardinal Health were worth $2,818,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also modified their holdings of the company. Frazier Financial Advisors LLC grew its stake in shares of Cardinal Health by 69.8% in the third quarter. Frazier Financial Advisors LLC now owns 253 shares of the company’s stock valued at $28,000 after acquiring an additional 104 shares in the last quarter. Promus Capital LLC acquired a new position in shares of Cardinal Health in the fourth quarter valued at about $30,000. AM Squared Ltd acquired a new position in shares of Cardinal Health in the third quarter valued at about $33,000. Kentucky Trust Co acquired a new position in shares of Cardinal Health in the fourth quarter valued at about $41,000. Finally, HHM Wealth Advisors LLC grew its stake in shares of Cardinal Health by 57.6% in the fourth quarter. HHM Wealth Advisors LLC now owns 394 shares of the company’s stock valued at $47,000 after acquiring an additional 144 shares in the last quarter. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on the stock. Argus set a $148.00 price target on shares of Cardinal Health in a research note on Tuesday, February 4th. Evercore ISI upgraded shares of Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 price objective on the stock in a research note on Tuesday, January 7th. TD Cowen upgraded shares of Cardinal Health from a “hold” rating to a “buy” rating and increased their price objective for the stock from $130.00 to $144.00 in a research note on Wednesday, January 8th. Citigroup increased their price objective on shares of Cardinal Health from $120.00 to $129.00 and gave the stock a “neutral” rating in a research note on Friday, January 10th. Finally, Mizuho assumed coverage on shares of Cardinal Health in a research note on Wednesday, December 4th. They set an “outperform” rating and a $139.00 price objective on the stock. Four investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. According to data from MarketBeat.com, Cardinal Health currently has an average rating of “Moderate Buy” and an average price target of $139.36.

Cardinal Health Trading Down 0.5 %

CAH opened at $126.40 on Monday. The company’s 50 day moving average is $125.58 and its 200-day moving average is $118.88. Cardinal Health, Inc. has a 1-year low of $93.17 and a 1-year high of $132.84. The company has a market cap of $30.53 billion, a P/E ratio of 23.58, a PEG ratio of 1.49 and a beta of 0.66.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. On average, equities analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be issued a $0.5056 dividend. The ex-dividend date is Tuesday, April 1st. This represents a $2.02 dividend on an annualized basis and a yield of 1.60%. Cardinal Health’s dividend payout ratio (DPR) is presently 37.69%.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.